Rho GTPase function in tumorigenesis

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1796, Issue 2, 2009, Pages 91-98

  Karlsson, R ^a   Pedersen, E D ^a   Wang, Z ^a   Brakebusch, Cord ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Rho GTPases

Indexed keywords

CELL PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN CDC42; PROTEIN RHOC; PROTEIN RHOE; PROTEIN RHOG; PROTEIN RHOH; PROTEIN RND1; PROTEIN RND2; PROTEIN RND3; RAC1 PROTEIN; RAC2 PROTEIN; RAC3 PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; RHOB GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

CANCER GROWTH; CARCINOGENESIS; CELL CYCLE REGULATION; CELL MIGRATION; CELL POLARITY; CELL SURVIVAL; ENZYME ACTIVITY; ENZYME ANALYSIS; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SOLID TUMOR; TRANSGENIC MOUSE; TUMOR VASCULARIZATION;

ANIMALS; CELL CYCLE; CELL MOVEMENT; CELL POLARITY; CELL SURVIVAL; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RHO GTP-BINDING PROTEINS; RHOA GTP-BINDING PROTEIN; RHOB GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION;

ANIMALIA; MUS;

EID: 70349187211     PISSN: 0304419X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbcan.2009.03.003     Document Type: Review

References (112)

1. Jaffe A.B., and Hall A. Rho GTPases: biochemistry and biology. Annu. Rev. Cell Dev. Biol. 21 (2005) 247-269
2. Filippi M.D., Harris C.E., Meller J., Gu Y., Zheng Y., and Williams D.A. Localization of Rac2 via the C terminus and aspartic acid 150 specifies superoxide generation, actin polarity and chemotaxis in neutrophils. Nat. Immunol. 7 (2004) 744-751
3. Adamson P., Paterson H.F., and Hall A. Intracellular localization of the P21rho proteins. J. Cell Biol. 119 (1992) 617-627
4. Bustelo X.R., Sauzeau V., and Berenjeno I.M. GTP-binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo. BioEssays 29 (2007) 356-370
5. Rossman K.L., Der C.J., and Sondek J. GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat. Rev., Mol. Cell Biol. 6 (2005) 167-180
6. Bernards R. Cancer: cues for migration. Nature 425 (2003) 247-248
7. Peck J., Douglas G.t., Wu C.H., and Burbelo P.D. Human RhoGAP domain-containing proteins: structure, function and evolutionary relationships. FEBS Lett. 528 (2002) 27-34
8. Wennerberg K., and Der C.J. Rho-family GTPases: it's not only Rac and Rho (and I like it). J. Cell Sci. 117 (2004) 1301-1312
9. DerMardirossian C., and Bokoch G.M. GDIs: central regulatory molecules in Rho GTPase activation. Trends Cell Biol. 15 (2005) 356-363
10. Olson M.F., Ashworth A., and Hall A. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science 269 (1995) 1270-1272
11. Qiu R.G., Abo A., McCormick F., and Symons M. Cdc42 regulates anchorage-independent growth and is necessary for Ras transformation. Mol. Cell Biol. 17 (1997) 3449-3458
12. Qiu R.G., Chen J., Kirn D., McCormick F., and Symons M. An essential role for Rac in Ras transformation. Nature 374 (1995) 457-459
13. Qiu R.G., Chen J., McCormick F., and Symons M. A role for Rho in Ras transformation. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 11781-11785
14. Klein E.A., Yang C., Kazanietz M.G., and Assoian R.K. NFkappaB-independent signaling to the cyclin D1 gene by Rac. Cell Cycle 6 (2007) 1115-1121
15. Villalonga P., and Ridley A.J. Rho GTPases and cell cycle control. Growth Factors 24 (2006) 159-164
16. Villalonga P., Guasch R.M., Riento K., and Ridley A.J. RhoE inhibits cell cycle progression and Ras-induced transformation. Mol. Cell Biol. 24 (2004) 7829-7840
17. Etienne-Manneville S. Cdc42-the centre of polarity. J. Cell Sci. 117 (2004) 1291-1300
18. Wu X., Li S., Chrostek-Grashoff A., Czuchra A., Meyer H., Yurchenco P.D., and Brakebusch C. Cdc42 is crucial for the establishment of epithelial polarity during early mammalian development. Dev. Dyn. 236 (2007) 2767-2778
19. Cappello S., Attardo A., Wu X., Iwasato T., Itohara S., Wilsch-Brauninger M., Eilken H.M., Rieger M.A., Schroeder T.T., Huttner W.B., Brakebusch C., and Gotz M. The Rho-GTPase cdc42 regulates neural progenitor fate at the apical surface. Nat. Neurosci. 9 (2006) 1099-1107
20. Wu X., Quondamatteo F., and Brakebusch C. Cdc42 expression in keratinocytes is required for the maintenance of the basement membrane in skin. Matrix Biol. 25 (2006) 466-474
21. Harris K.P., and Tepass U. Cdc42 and Par proteins stabilize dynamic adherens junctions in the Drosophila neuroectoderm through regulation of apical endocytosis. J. Cell Biol. 183 (2008) 1129-1143
22. Georgiou M., Marinari E., Burden J., and Baum B. Cdc42, Par6, and aPKC regulate Arp2/3-mediated endocytosis to control local adherens junction stability. Curr. Biol. 18 (2008) 1631-1638
23. Leibfried A., Fricke R., Morgan M.J., Bogdan S., and Bellaiche Y. Drosophila Cip4 and WASp define a branch of the Cdc42-Par6-aPKC pathway regulating E-cadherin endocytosis. Curr. Biol. 18 (2008) 1639-1648
24. Braga V.M., Del Maschio A., Machesky L., and Dejana E. Regulation of cadherin function by Rho and Rac: modulation by junction maturation and cellular context. Mol. Biol. Cell 10 (1999) 9-22
25. Braga V.M., Machesky L.M., Hall A., and Hotchin N.A. The small GTPases Rho and Rac are required for the establishment of cadherin-dependent cell-cell contacts. J. Cell Biol. 137 (1997) 1421-1431
26. Liu A.X., Rane N., Liu J.P., and Prendergast G.C. RhoB is dispensable for mouse development, but it modifies susceptibility to tumor formation as well as cell adhesion and growth factor signaling in transformed cells. Mol. Cell Biol. 21 (2001) 6906-6912
27. Hakem A., Sanchez-Sweatman O., You-Ten A., Duncan G., Wakeham A., Khokha R., and Mak T.W. RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis. Genes Dev. 19 (2005) 1974-1979
28. Benitah S.A., and Watt F.M. Epidermal deletion of Rac1 causes stem cell depletion, irrespective of whether deletion occurs during embryogenesis or adulthood. J. Invest. Dermatol. 127 (2007) 1555-1557
29. Castilho R.M., Squarize C.H., Patel V., Millar S.E., Zheng Y., Molinolo A., and Gutkind J.S. Requirement of Rac1 distinguishes follicular from interfollicular epithelial stem cells. Oncogene 26 (2007) 5078-5085
30. Chrostek A., Wu X., Quondamatteo F., Hu R., Sanecka A., Niemann C., Langbein L., Haase I., and Brakebusch C. Rac1 is crucial for hair follicle integrity but is not essential for maintenance of the epidermis. Mol. Cell Biol. 26 (2006) 6957-6970
31. Aspenstrom P., Fransson A., and Saras J. Rho GTPases have diverse effects on the organization of the actin filament system. Biochem. J. 377 (2004) 327-337
32. Wheeler A.P., and Ridley A.J. Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility. Exp. Cell Res. 301 (2004) 43-49
33. Etienne-Manneville S., Manneville J.B., Nicholls S., Ferenczi M.A., and Hall A. Cdc42 and Par6-PKCzeta regulate the spatially localized association of Dlg1 and APC to control cell polarization. J. Cell Biol. 170 (2005) 895-901
34. Yang L., Wang L., and Zheng Y. Gene targeting of Cdc42 and Cdc42GAP affirms the critical involvement of Cdc42 in filopodia induction, directed migration, and proliferation in primary mouse embryonic fibroblasts. Mol. Biol. Cell 17 (2006) 4675-4685
35. Czuchra A., Wu X., Meyer H., van Hengel J., Schroeder T., Geffers R., Rottner K., and Brakebusch C. Cdc42 is not essential for filopodium formation, directed migration, cell polarization, and mitosis in fibroblastoid cells. Mol. Biol. Cell 16 (2005) 4473-4484
36. Sanz-Moreno V., Gadea G., Ahn J., Paterson H., Marra P., Pinner S., Sahai E., and Marshall C.J. Rac activation and inactivation control plasticity of tumor cell movement. Cell 135 (2008) 510-523
37. Aznar S., and Lacal J.C. Rho signals to cell growth and apoptosis. Cancer Lett. 165 (2001) 1-10
38. Ma Z., Myers D.P., Wu R.F., Nwariaku F.E., and Terada L.S. p66Shc mediates anoikis through RhoA. J. Cell Biol. 179 (2007) 23-31
39. Del Re D.P., Miyamoto S., and Brown J.H. RhoA/Rho kinase up-regulate Bax to activate a mitochondrial death pathway and induce cardiomyocyte apoptosis. J. Biol. Chem. 282 (2007) 8069-8078
40. Hébert M., Potin S., Sebbagh M., Bertoglio J., Bréard J., and Hamelin J. Rho-ROCK-dependent ezrin-radixin-moesin phosphorylation regulates Fas-mediated apoptosis in Jurkat cells. J. Immunol. 181 (2008) 5963-5973
41. Zhu S., Korzh V., Gong Z., and Low B.C. RhoA prevents apoptosis during zebrafish embryogenesis through activation of Mek/Erk pathway. Oncogene 27 (2008) 1580-1589
42. Ramaswamy M., Dumont C., Cruz A.C., Muppidi J.R., Gomez T.S., Billadeau D.D., Tybulewicz V.L., and Siegel R.M. Cutting edge: Rac GTPases sensitize activated T cells to die via Fas. J. Immunol. 179 (2007) 6384-6388
43. Friedland J.C., Lakins J.N., Kazanietz M.G., Chernoff J., Boettiger D., and Weaver V.M. alpha6beta4 integrin activates Rac-dependent p21-activated kinase 1 to drive NF-kappaB-dependent resistance to apoptosis in 3D mammary acini. J. Cell Sci. 120 (2007) 3700-3712
44. Chaigne-Delalande B., Anies G., Kramer I., and Genot E. Nonadherent cells switch to a Rac-mediated, SHIP regulated, Akt activation mode for survival. Oncogene 27 (2008) 1876-1885
45. Matos P., and Jordan P. Increased Rac1b expression sustains colorectal tumor cell survival. Mol. Cancer Res. 6 (2008) 1178-1184
46. Li K., Lu Y., Liang J., Luo G., Ren G., Wang X., and Fan D. RhoE enhances multidrug resistance of gastric cancer cells by suppressing Bax. Biochem. Biophys. Res. Commun. 379 (2009) 212-216
47. Yamaki N., Negishi M., and Katoh H. RhoG regulates anoikis through a phosphatidylinositol 3-kinase-dependent mechanism. Exp. Cell Res. 313 (2007) 2821-2832
48. Bryan B.A., and D'Amore P.A. What tangled webs they weave: Rho-GTPase control of angiogenesis. Cell Mol. Life Sci. 64 (2007) 2053-2065
49. Turcotte S., Desrosiers R.R., and Béliveau R. HIF-1alpha mRNA and protein upregulation involves Rho GTPase expression during hypoxia in renal cell carcinoma. J. Cell Sci. 116 (2003) 2247-2260
50. van Golen K.L., Wu Z.F., Qiao X.T., Bao L., and Merajver S.D. HIF-1alpha mRNA and protein upregulation involves Rho GTPase expression during hypoxia in renal cell carcinoma. Neoplasia 2 (2000) 418-425
51. Lane J., Martin T.A., Mansel R.E., and Jiang W.G. The expression and prognostic value of the guanine nucleotide exchange factors (GEFs) Trio, Vav1 and TIAM-1 in human breast cancer. Int. Semin. Surg. Oncol. 5 (2008) 23-30
52. Fukui K., Tamura S., Wada A., Kamada Y., Sawai Y., Imanaka K., Kudara T., Shimomura I., and Hayashi N. Expression and prognostic role of RhoA GTPases in hepatocellular carcinoma. J. Cancer Res. Clin. Oncol. 132 (2006) 627-633
53. Li X.R., Ji F., Ouyang J., Wu W., Qian L.Y., and Yang K.Y. Overexpression of RhoA is associated with poor prognosis in hepatocellular carcinoma. Eur. J. Surg. Oncol. 32 (2006) 1130-1134
54. Abraham M.T., Kuriakose M.A., Sacks P.G., Yee H., Chiriboga L., Bearer E.L., and Delacure M.D. Motility-related proteins as markers for head and neck squamous cell cancer. Laryngoscope 111 (2001) 1285-1289
55. Adnane J., Muro-Cacho C., Mathews L., Sebti S.M., and Munoz-Antonia T. Suppression of rho B expression in invasive carcinoma from head and neck cancer patients. Clin. Cancer Res. 8 (2002) 2225-2232
56. Fritz G., Just I., and Kaina B. Rho GTPases are over-expressed in human tumors. Int. J. Cancer 81 (1999) 682-687
57. Horiuchi A., Imai T., Wang C., Ohira S., Feng Y., Nikaido T., and Konishi I. Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma. Lab. Invest. 83 (2003) 861-870
58. Kamai T., Tsujii T., Arai K., Takagi K., Asami H., Ito Y., and Oshima H. Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin. Cancer Res. 9 (2003) 2632-2641
59. Pan Y., Bi F., Liu N., Xue Y., Yao X., Zheng Y., and Fan D. Expression of seven main Rho family members in gastric carcinoma. Biochem. Biophys. Res. Commun. 315 (2004) 686-691
60. Faried A., Faried L.S., Usman N., Kato H., and Kuwano H. Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma. Ann. Surg. Oncol. 14 (2007) 3593-3601
61. Kamai T., Yamanishi T., Shirataki H., Takagi K., Asami H., Ito Y., and Yoshida K. Overexpression of RhoA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer. Clin. Cancer Res. 10 (2004) 4799-4805
62. Jiang W.G., Watkins G., Lane J., Cunnick G.H., Douglas-Jones A., Mokbel K., and Mansel R.E. Prognostic value of rho GTPases and rho guanine nucleotide dissociation inhibitors in human breast cancers. Clin. Cancer Res. 9 (2003) 6432-6440
63. Henning S.W., Galandrini R., Hall A., and Cantrell D.A. The GTPase Rho has a critical regulatory role in thymus development. EMBO J. 16 (1997) 2397-2407
64. Cleverley S.C., Costello P.S., Henning S.W., and Cantrell D.A. Loss of Rho function in the thymus is accompanied by the development of thymic lymphoma. Oncogene 19 (2000) 13-20
65. Horiuchi A., Kikuchi N., Osada R., Wang C., Hayashi A., Nikaido T., and Konishi I. Overexpression of RhoA enhances peritoneal dissemination: RhoA suppression with Lovastatin may be useful for ovarian cancer. Cancer Sci. 99 (2008) 2532-2539
66. Fritz G., Brachetti C., Bahlmann F., Schmidt M., and Kaina B. Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters. Br. J. Cancer 87 (2002) 635-644
67. Mazieres J., Antonia T., Daste G., Muro-Cacho C., Berchery D., Tillement V., Pradines A., Sebti S., and Favre G. Loss of RhoB expression in human lung cancer progression. Clin. Cancer Res. 10 (2004) 2742-2750
68. Couderc B., Pradines A., Rafii A., Golzio M., Deviers A., Allal C., Berg D., Penary M., Teissie J., and Favre G. In vivo restoration of RhoB expression leads to ovarian tumor regression. Cancer Gene Ther. 15 (2008) 456-464
69. van Golen K.L., Davies S., Wu Z.F., Wang Y., Bucana C.D., Root H., Chandrasekharappa S., Strawderman M., Ethier S.P., and Merajver S.D. A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. Clin. Cancer Res. 5 (1999) 2511-2519
70. Marionnet C., Lalou C., Mollier K., Chazal M., Delestaing G., Compan D., Verola O., Vilmer C., Cuminet J., Dubertret L., and Basset-Seguin N. Differential molecular profiling between skin carcinomas reveals four newly reported genes potentially implicated in squamous cell carcinoma development. Oncogene 22 (2003) 3500-3505
71. Suwa H., Ohshio G., Imamura T., Watanabe G., Arii S., Imamura M., Narumiya S., Hiai H., and Fukumoto M. Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas. Br. J. Cancer 77 (1998) 147-152
72. Wang W., Yang L.Y., Huang G.W., Lu W.Q., Yang Z.L., Yang J.Q., and Liu H.L. Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis. Br. J. Cancer 90 (2004) 2349-2355
73. Wang W., Yang L.Y., Yang Z.L., Huang G.W., and Lu W.Q. Expression and significance of RhoC gene in hepatocellular carcinoma. World J. Gastroenterol. 9 (2003) 1950-1953
74. Kleer C.G., Griffith K.A., Sabel M.S., Gallagher G., van Golen K.L., Wu Z.F., and Merajver S.D. RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast. Breast Cancer Res. Treat. 93 (2005) 101-110
75. Liu N., Zhang G., Bi F., Pan Y., Xue Y., Shi Y., Yao L., Zhao L., Zheng Y., and Fan D. RhoC is essential for the metastasis of gastric cancer. J. Mol. Med. 85 (2007) 1149-1156
76. Kondo T., Sentani K., Oue N., Yoshida K., Nakayama H., and Yasui W. Expression of RhoC is associated with metastasis of gastric carcinomas. Pathobiology 71 (2004) 19-25
77. Kleer C.G., Teknos T.N., Islam M., Marcus B., Lee J.S., Pan Q., and Merajver S.D. RhoC GTPase expression as a potential marker of lymph node metastasis in squamous cell carcinomas of the head and neck. Clin. Cancer Res. 12 (2006) 4485-4490
78. Iiizumi M., Bandyopadhyay S., Pai S.K., Watabe M., Hirota S., Hosobe S., Tsukada T., Miura K., Saito K., Furuta E., Liu W., Xing F., Okuda H., Kobayashi A., and Watabe K. RhoC promotes metastasis via activation of the Pyk2 pathway in prostate cancer. Cancer Res. 68 (2008) 7613-7620
79. Shikada Y., Yoshino I., Okamoto T., Fukuyama S., Kameyama T., and Maehara Y. Higher expression of RhoC is related to invasiveness in non-small cell lung carcinoma. Clin. Cancer Res. 9 (2003) 5282-5286
80. Clark E.A., Golub T.R., Lander E.S., and Hynes R.O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406 (2000) 532-535
81. Boone B., Van Gele M., Lambert J., Haspeslagh M., and Brochez L. The role of RhoC in growth and metastatic capacity of melanoma. Cutan Pathol. (2009 Feb 5) [Electronic publication ahead of print]
82. Dilworth S.M. Polyoma virus middle T antigen and its role in identifying cancer-related molecules. Nat. Rev. Cancer 2 (2002) 951-956
83. Wang W., Wu F., Fang F., Tao Y., and Yang L. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo. Clin. Cancer Res. 14 (2008) 6804-6812
84. Schnelzer A., Prechtel D., Knaus U., Dehne K., Gerhard M., Graeff H., Harbeck N., Schmitt M., and Lengyel E. Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b. Oncogene 19 (2000) 3013-3020
85. Liu S.Y., Yen C.Y., Yang S.C., Chiang W.F., and Chang K.W. Overexpression of Rac-1 small GTPase binding protein in oral squamous cell carcinoma. J. Oral Maxillofac. Surg. 62 (2004) 702-707
86. Jordan P., Brazao R., Boavida M.G., Gespach C., and Chastre E. Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors. Oncogene 18 (1999) 6835-6839
87. Engers R., Ziegler S., Mueller M., Walter A., Willers R., and Gabbert H.E. Prognostic relevance of increased Rac GTPase expression in prostate carcinomas. Endocr.-Relat. Cancer 14 (2007) 245-256
88. Espina C., Céspedes M.V., García-Cabezas M.A., Gómez del Pulgar M.T., Boluda A., Oroz L.G., Benitah S.A., Cejas P., Nistal M., Mangues R., and Lacal J.C. A critical role for Rac1 in tumor progression of human colorectal adenocarcinoma cells. Am. J. Pathol. 172 (2008) 156-166
89. Kissil J.L., Walmsley M.J., Hanlon L., Haigis K.M., Bender Kim C.F., Sweet-Cordero A., Eckman M.S., Tuveson D.A., Capobianco A.J., Tybulewicz V.L., and Jacks T. Requirement for Rac1 in a K-ras induced lung cancer in the mouse. Cancer Res. 67 (2007) 8089-8094
90. Harnois T., Constantin B., Rioux A., Grenioux E., Kitzis A., and Bourmeyster N. Differential interaction and activation of Rho family GTPases by p210bcr-abl and p190bcr-abl. Oncogene 22 (2003) 6445-6454
91. Thomas E.K., Cancelas J.A., Chae H.D., Cox A.D., Keller P.J., Perrotti D., Neviani P., Druker B.J., Setchell K.D., Zheng Y., Harris C.E., and Williams D.A. Rac guanosine triphosphatases represent integrating molecular therapeutic targets for BCR-ABL-induced myeloproliferative disease. Cancer Cell 12 (2007) 467-478
92. Mira J.P., Benard V., Groffen J., Sanders L.C., and Knaus U.G. Endogenous, hyperactive Rac3 controls proliferation of breast cancer cells by a p21-activated kinase-dependent pathway. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 185-189
93. Leung K., Nagy A., Gonzalez-Gomez I., Groffen J., Heisterkamp N., and Kaartinen V. Targeted expression of activated Rac3 in mammary epithelium leads to defective postlactational involution and benign mammary gland lesions. Cells Tissues Organs 175 (2003) 72-83
94. Cho Y.J., Zhang B., Kaartinen V., Haataja L., de Curtis I., Groffen J., and Heisterkamp N. Generation of rac3 null mutant mice: role of Rac3 in Bcr/Abl-caused lymphoblastic leukemia. Mol. Cell Biol. 25 (2005) 5777-5785
95. Vigorito E., Bell S., Hebeis B.J., Reynolds H., McAdam S., Emson P.C., McKenzie A., and Turner M. Immunological function in mice lacking the Rac-related GTPase RhoG. Mol. Cell Biol. 24 (2004) 719-729
96. Na S., Li B., Grewal I.S., Enslen H., Davis R.J., Hanke J.H., and Flavell R.A. Expression of activated CDC42 induces T cell apoptosis in thymus and peripheral lymph organs via different pathways. Oncogene 18 (1999) 7966-7974
97. van Hengel J., D'Hooge P., Hooghe B., Wu X., Libbrecht L., De Vos R., Quondamatteo F., Klempt M., Brakebusch C., and van Roy F. Continuous cell injury promotes hepatic tumorigenesis in cdc42-deficient mouse liver. Gastroenterology 134 (2008) 781-792
98. Yang L., Wang L., Kalfa T.A., Cancelas J.A., Shang X., Pushkaran S., Mo J., Williams D.A., and Zheng Y. Cdc42 critically regulates the balance between myelopoiesis and erythropoiesis. Blood 110 (2007) 3853-3861
99. Cuiyan Z., Jie H., Fang Z., Kezhi Z., Junting W., Susheng S., Xiaoli F., Ning L., Xinhua M., Zhaoli C., Kang S., Bin Q., Baozhong L., Sheng C., and Meihua X. Overexpression of RhoE in non-small cell lung cancer (NSCLC) is associated with smoking and correlates with DNA copy number changes. Cancer Biol. Ther. 6 (2007) 335-342
100. Zhang C., Zhou F., Li N., Shi S., Feng X., Chen Z., Hang J., Qiu B., Li B., Chang S., Wan J., Shao K., Xing X., Tan X., Wang Z., Xiong M., and He J. Overexpression of RhoE has a prognostic value in non-small cell lung cancer. Ann. Surg. Oncol. 14 (2007) 2628-2635
101. Gress T.M., Muller-Pillasch F., Geng M., Zimmerhackl F., Zehetner G., Friess H., Buchler M., Adler G., and Lehrach H. A pancreatic cancer-specific expression profile. Oncogene 13 (1996) 1819-1830
102. Bektic J., Pfeil K., Berger A.P., Ramoner R., Pelzer A., Schafer G., Kofler K., Bartsch G., and Klocker H. Small G-protein RhoE is underexpressed in prostate cancer and induces cell cycle arrest and apoptosis. Prostate 64 (2005) 332-340
103. Dallery-Prudhomme E., Roumier C., Denis C., Preudhomme C., Kerckaert J.P., and Galiegue-Zouitina S. Genomic structure and assignment of the RhoH/TTF small GTPase gene (ARHH) to 4p13 by in situ hybridization. Genomics 43 (1997) 89-94
104. Preudhomme C., Roumier C., Hildebrand M.P., Dallery-Prudhomme E., Lantoine D., Lai J.L., Daudignon A., Adenis C., Bauters F., Fenaux P., Kerckaert J.P., and Galiegue-Zouitina S. Nonrandom 4p13 rearrangements of the RhoH/TTF gene, encoding a GTP-binding protein, in non-Hodgkin's lymphoma and multiple myeloma. Oncogene 19 (2000) 2023-2032
105. Pasqualucci L., Neumeister P., Goossens T., Nanjangud G., Chaganti R.S., Kuppers R., and Dalla-Favera R. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 412 (2001) 341-346
106. Dijkman R., Tensen C.P., Buettner M., Niedobitek G., Willemze R., and Vermeer M.H. Primary cutaneous follicle center lymphoma and primary cutaneous large B-cell lymphoma, leg type, are both targeted by aberrant somatic hypermutation but demonstrate differential expression of AID. Blood 107 (2006) 4926-4929
107. Libra M., Capello D., Gloghini A., Laura P., Berra E., Cerri M., Gasparotto D., Franca S., De Re V., Gaidano G., and Carbone A. Analysis of aberrant somatic hypermutation (SHM) in non-Hodgkin's lymphomas of patients with chronic HCV infection. J. Pathol. 206 (2005) 87-91
108. Hiraga J., Katsumi A., Iwasaki T., Abe A., Kiyoi H., Matsushita T., Kinoshita T., and Naoe T. Prognostic analysis of aberrant somatic hypermutation of RhoH gene in diffuse large B cell lymphoma. Leukemia 21 (2007) 1846-1847
109. Iwasaki T., Katsumi A., Kiyoi H., Tanizaki R., Ishikawa Y., Ozeki K., Kobayashi M., Abe A., Matsushita T., Watanabe T., Amano M., Kojima T., Kaibuchi K., and Naoe T. Prognostic implication and biological roles of RhoH in acute myeloid leukaemia. Eur. J. Haematol. 81 (2008) 454-460
110. Galiègue-Zouitina S., Delestré L., Dupont C., Troussard X., and Shelley C.S. Underexpression of RhoH in hairy cell leukemia. Cancer Res. 68 (2008) 4531-4540
111. Dorn T., Kuhn U., Bungartz G., Stiller S., Bauer M., Ellwart J., Peters T., Scharffetter-Kochanek K., Semmrich M., Laschinger M., Holzmann B., Klinkert W.E., Straten P.T., Kollgaard T., Sixt M., and Brakebusch C. RhoH is important for positive thymocyte selection and T-cell receptor signaling. Blood 109 (2007) 2346-2355
112. Gu Y., Chae H.D., Siefring J.E., Jasti A.C., Hildeman D.A., and Williams D.A. RhoH GTPase recruits and activates Zap70 required for T cell receptor signaling and thymocyte development. Nat. Immunol. 7 (2006) 1182-1190